Publications: Year 2001
ABONIA JP, HOWLES PN, ABEL KJ, BLACK TA, JONES CA, GROSS KW. Evaluating a model of the NRE mediated tissue-specific expression of the murine renin genes. Hypertension 37:105-109, 2001.
ANIKSTER Y, HUIZING M, WHITE J, SHEVCHENKO YO, FITZPATRICK DL, TOUCHMAN JW, COMPTON JG, BALE SJ, SWANK RT, GAHL WA, TORO JR. Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet 28:376-380, 2001.
ARREDOUANI M, MATTHYS P, KASRAN A, BAUMANN H, CEUPPEN JL. Haptoglobin and the Th1/Th2 balance: hints from in vitro and in vivo studies. Redox Rep 6(6):369-371, 2001.
BARBOUR KW, DAVIS T, WHITE A, BAUMANN H, BERGER FG. Haptoglobin, inflammation, and tumorigenesis in the MIN mouse. Redox Rep 6(6):366-368, 2001.
BIGG HF, MORRISON CJ, BUTLER GS, BOGOYEVITCH MA, WANG Z, SOLOWAY PD, OVERALL CM. Tissue inhibitor of metalloproteinases-4 (TIMP-4) inhibits but does not support the activation of gelatinase A (MMP-2) via efficient inhibition of membrane type-1 matrix metalloproteinase. Cancer Res 61:3610-3618, 2001.
BLANCHARD F, WANG Y, KINZIE E, DUPLOMB L, GODARD A, BAUMANN H. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitor factor receptor alpha and oncostatin M receptor beta by distinct mechanisms. J Biol Chem 276:47038-47045, 2001.
CHADHA KC, KAWINSKI E, SULKOWSKI E. Thiophilic interaction chromatography of prostate-specific antigen. J Chromatog B: Biomed Appl 754(2):521-525, 2001.
CHADHA KC, SULKOWSKI E, KAWINSKI E. A method for detection of PSA and its molecular forms using thiophilic gel. U.S. Patent Application # 09,624,692. Awarded 12/5/01.
CHADHA KC, SYKES DE, DEMBINSKI WE, AMBRUS JL SR. Why do most cancer patients respond poorly to interferon therapy? Proc Intnl Symp Recent Advances in Molecular Biology, Allergy and Immunology, Sept. 3-5, 2000, Baroda, India. Allied Publisher Ltd., New Delhi, India, pp 179-185, 2001.
CHERVINSKY DS, LAM DH, MELMAN MP, GROSS KW, APLAN PD. SCID thymocytes with TCRb gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. Cancer Res 61:6382-6387, 2001.
CHIN JY, LEISTER KJ, WENNER CE. Density differential responses of embryonic fibroblast. In Vitro Cell Dev Biol Anim 37:263-265, 2001.
COUSSENS LM, SHAPIRO SD, SOLOWAY PD, WERB Z. Models for gain-of-function and loss-of-function of MMPs. Transgenic and gene targeted mice. Meth Mol Biol 151:149-179, 2001.
DALZIEL M, HUANG R-A, DALL’OLIO F, MORRIS JR, TAYLOR-PAPADIMITRIOU J, LAU JTY. Mouse ST6Gal sialyltransferase gene expression during mammary gland lactation and carcinoma. Glycobiology 11:407-412, 2001.
ELLIOTT RW, MILLER DR, PEARSALL RS, HOHMAN C, ZHANG Y, POSLINSKI D, TABACZYNSKI DA, CHAPMAN VM. Genetic analysis of testis weight and fertility in an interspecies hybrid congenic strain for Chr X. Mamm Genome 12:45-51, 2001.
HEMBERGER M, KURZ H, ORTH A, OTTO S, LUTTGES A, ELLIOTT R, NAGY A, TAN S-S, TAM P, ZECHNER U, FUNDELE RH. Genetic and developmental analysis of X-inactivation of interspecific hybrid mice suggests a role for the Y-chromosome in placental dysplasia. Genetics 157:341-348, 2001.
HERNANDEZ-BARRANTES S, SHIMURA Y, SOLOWAY PD, SANG QA, FRIDMAN R. Differential roles of TIMP-4 and TIMP-2 in Pro-MMP-2 activation by MT1-MMP. Biochem Biophys Res Comm 281:126-130, 2001.
HO AT, VOURA EB, WATSON KLM, SOLOWAY PD, KHOKHA R. MMP inhibitors augment fibroblast adhesion through stabilization of focal contacts and upregulation of cadherin function. J Biol Chem 276:40215-40224, 2001.
JOHNSON M, MAHMOOD S, HYATT SL, YANG H-S, SOLOWAY PD, HANSON R, PATEL M. Inactivation of murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development. Mol Genet Metab 74:293-302, 2001.
KIM H, ODA T, LOPEZ-GUISA J, WING D, EDWARDS DR, SOLOWAY PD, EDDY A. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy. J Am Soc Nephrol 4:736-748, 2001.
LI W, ELLIOTT RW, NOVAK EK, SWANK RT. cDNA sequence and mapping of the mouse Copb gene encoding the beta subunit of the COP1 coatomer complex. Somat Cell Mol Genet 25:177-183, 2001.
MANLY KF, CUDMORE RH JR, MEER JM. Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 12:930-932, 2001.
MORRISON CJ, BUTLER GS, BIGG HF, ROBERTS CR, SOLOWAY PD, OVERALL CM. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem 276:47402-47410, 2001.
NAIR MP, MAHAJAN S, CHADHA KC, NAIR NM, HEWITT RG, PILAI SK, CHADHA P, SUKUMARAN PC, SCHWARTZ SA. Effect of cocaine on chemokine and CCR-5 gene expression by mononuclear cells from normal donors and HIV-1 infected patients. Adv Exp Med Biol 493:235-240, 2001.
PAN L, BLACK TA, SHI Q, JONES CA, PETROVIC N, LOUDON J, KANE C, SIGMUND CD, GROSS KW. Critical roles of a cyclic AMP responsive element and an E-box in the regulation of mouse renin gene expression. J Biol Chem 276:45530-45538, 2001.
PAN L, XIE Y, BLACK TA, JONES CA, PRUITT SC, GROSS KW. An Abd-B class Hox/Pbx recognition sequence is required for expression from the mouse Ren-1C gene. J Biol Chem 276:32489-32494, 2001.
RUSH LJ, DAI Z, SMIRAGLIA DJ, GAO X, WRIGHT F, FRUHWALD M, COSTELLO JF, HELD WA, YU L, KRAHE R, KOLITZ JE, BLOOMFIELD CD, CALIGIURI MA, PLASS C. Novel methylation targets in de novo acute myeloid leukemia with prevalence of chromosome 11 loci. Blood 97:3226-3233, 2001.
SHI Q, GROSS KW, SIGMUND CD. NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension 38:332-336, 2001.
SHI Q, GROSS KW, SIGMUND CD. Retinoic acid-mediated activation of the mouse renin enhancer. J Biol Chem 276:3597-3603, 2001.
SMIRAGLIA DJ, RUSH LJ, FRUHWALD MC, DAI Z, HELD WA, COSTELLO JF, LANG JC, ENG C, WRIGHT FA, CALIGIURI MA, PLASS C. Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genetics 10:1413-1419, 2001.
SUZUKI T, LI W, ZHANG Q, NOVAK EK, SVIDERSKAYA EV, WILSON A, BENNETT DC, ROE BA, SWANK RT, SPRITZ RA. T he gene mutated in cocoa mice, carrying a defect of organelle biogenesis, is a homologue of the human Hermansky-Pudlak syndrome-3 gene. Genomics 78:30-37, 2001.
TATENO M, FUKUNISHI Y, KOMATSU S, OKAZAKI Y, KAWAI J, SHIBATA K, ITO M, MURAMATSU M, HELD WA, HAYASHIZAKI Y. Identification of a novel member of the SNAG repressor family, mlc 1, which is methylated and silenced in liver tumors of SV40 T antigen transgenic mice. Cancer Res 61:1144-1153, 2001.
VAILLANT B, CHIARAMONTE MG, CHEEVER AW, SOLOWAY P, WYNN TA. Regulation of hepatic fibrosis and extracellular-matrix genes by the T-helper response: new insight into the role of tissue inhibitors of matrix metalloproteinases. J Immunol 167:7017-7026, 2001.
WANG Y, KINZIE E, BERGER FG, LIM S-K, BAUMANN H. Haptoglobin, an inflammation-inducible plasma protein. Redox Rep 6(6):379-385, 2001.
XIA Z, SAIT SNJ, BAER MR, BARCOS M, DONOHUE KA, LAWRENCE D, FORD LA, BLOCK AMW, BAUMANN H, WETZLER M. Truncated STAT proteins are prevalent at relapse of acute myeloid leukemia. Leuk Res 25:473-482, 2001.
XIA Z, SALZLER RR, KUNZ DP, BAER MR, KAZIM L, BAUMANN H, WETZLER M. A novel serine-dependent proteolytic activity is responsible for truncated signal transducer and activator of transcription proteins in acute myeloid leukemia blasts. Cancer Res 61:1747-1753, 2001.
YAMADA E, TOBE T, YAMADA N, OKAMOTO DJ, ZACK J, WERB Z., SOLOWAY PD, CAMPOCHIARO PA. TIMP-1 promotes VEGF-induced neovascularization in the retina. Histol Histopathol 16:87-97, 2001.
YAN S, WENNER CE. Modulation of cyclin D1 and its signaling components by the phorbol ester TPA and the tyrosine phosphatase inhibitor vanadate. J Cell Physiol 186:338-349, 2001.


